As a China and US based biotech, Drug Farm is developing first-in-class drugs in the fields of hepatitis B, cancer and autoimmune diseases using its platform mouse genetics and AI technologies
Location: China
Employees: 51-200
Total raised: $111M
Founded date: 2015
Funding Rounds 2
| Date | Series | Amount | Investors |
| 14.07.2026 | Series D | $55M | BVCF |
| 09.02.2021 | Series A | $56M | - |
Mentions in press and media 8
| Date | Title | Description |
| 20.07.2026 | Drug Farm Secures $55 Million Series D, Accelerating AI-Powered Drug Development | Drug Farm closed a $55M Series D, fueling its AI-driven drug pipeline. The NYC-Shanghai biotech will advance clinical programs for DF-003, targeting ROSAH syndrome and cardiovascular disease, and DF-006 for hepatitis B. Its proprietary plat... |
| 14.07.2026 | Drug Farm Raises $55M in First Close of Series D Funding | Drug Farm, a NYC- and Shanghai, China-based biotechnology company developing novel drug targets, raised $55M in first close of its Series D financing. The round was Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collabor... |
| 13.07.2026 | Drug Farm Completes First Closing Of $55 Million Series D Financing | Drug Farm announced the successful first closing of its $55 million Series D financing to advance its clinical and preclinical development pipeline. The round was co-led by Shanghai Pudong Leading Area Investment Center and Shanghai Puxing ... |
| 09.02.2021 | Drug Farm Closes $56M Financing | SHANGHAI & GUILFORD, Conn.--(BUSINESS WIRE)--Drug Farm, a China- and US-based biotechnology company utilizing genetics and AI technologies to discover and develop innovative, immune-modulating therapies, has completed financing totaling... |
| 09.02.2021 | Drug Farm Closes $56M Financing | Drug Farm, a Shangai, China- and Guilford, MA-based biotechnology company utilizing genetics and AI technologies to discover and develop innovative, immune-modulating therapies, completed financing totaling $56m USD. Backers included BioVed... |
| 09.02.2021 | Drug Farm Closes $56M USD Financing for Advancement of Lead Hepatitis B Drug into Clinical Trials | SHANGHAI & GUILFORD, Conn.–(BUSINESS WIRE)–Feb 9, 2021– Drug Farm, a China- and US-based biotechnology company utilizing genetics and AI technologies to discover and develop innovative, immune-modulating therapies, has completed financi... |
| - | Drug Farm | - |
| - | Drug Farm | “Drug Farm” |